Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-1 vs TS-1 + PSK in Advanced Gastric Cancer
NCT00503321Phase 3Terminated
- Sponsor
- ENCIT
- Start
- Oct 2006
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes, Microbiome-Derived Products
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of polysaccharide k in gastric cancer (GC) (2 arms), sponsored by ENCIT. Primary endpoint: Progression-Free Survival at 6 months. Started Oct 2006; status: terminated.
02
Drugs
polysaccharide k
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00503321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00503321.